Parallel Advisors, LLC Astrazeneca PLC Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Parallel Advisors, LLC holds 20,996 shares of AZN stock, worth $1.39 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

20,996

Previous 20,753 1.17%

Holding current value

$1.39 Million

Previous $1.62 Million 1.11%

% of portfolio

0.04%

Previous 0.04%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $18,630 - $21,291	243 Added 1.17%	20,996 $1.64 Million
Q2 2024 Aug 08, 2024	BUY	$66.81 - $80.83 $132,484 - $160,285	1,983 Added 10.56%	20,753 $1.62 Million
Q1 2024 May 06, 2024	BUY	$61.03 - $69.57 $272,071 - $310,143	4,458 Added 31.15%	18,770 $1.27 Million
Q4 2023 Feb 09, 2024	SELL	$61.89 - $69.28 $10,459 - $11,708	-169 Reduced 1.17%	14,312 $963,000
Q3 2023 May 20, 2024	BUY	$64.85 - $71.7 $42,152 - $46,605	650 Added 4.7%	14,481 $980,000
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $42,152 - $46,605	650 Added 4.7%	14,481 $980,000
Q2 2023 May 20, 2024	BUY	$69.91 - $75.81 $29,851 - $32,370	427 Added 3.19%	13,831 $989,000
Q2 2023 Aug 04, 2023	BUY	$69.91 - $75.81 $29,851 - $32,370	427 Added 3.19%	13,831 $989,000
Q1 2023 May 20, 2024	SELL	$63.15 - $71.6 $338,862 - $384,205	-5,366 Reduced 28.59%	13,404 $930,000
Q1 2023 Apr 25, 2023	BUY	$63.15 - $71.6 $11,240 - $12,744	178 Added 1.35%	13,404 $930,000
Q4 2022 Feb 03, 2023	SELL	$54.21 - $70.44 $44,669 - $58,042	-824 Reduced 5.86%	13,226 $896,000
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $137,852 - $352,950	2,600 Added 22.71%	14,050 $770,000
Q2 2022 Aug 01, 2022	SELL	$59.26 - $71.14 $13,511 - $16,219	-228 Reduced 1.95%	11,450 $757,000
Q1 2022 Apr 28, 2022	SELL	$55.72 - $67.12 $139,411 - $167,934	-2,502 Reduced 17.64%	11,678 $784,000
Q4 2021 Jan 20, 2022	BUY	$54.02 - $63.83 $12,046 - $14,234	223 Added 1.6%	14,180 $826,000
Q3 2021 Nov 02, 2021	BUY	$55.56 - $60.79 $126,010 - $137,871	2,268 Added 19.4%	13,957 $838,000
Q2 2021 Aug 06, 2021	BUY	$48.42 - $60.18 $31,715 - $39,417	655 Added 5.94%	11,689 $700,000
Q1 2021 Apr 23, 2021	SELL	$47.16 - $54.44 $29,427 - $33,970	-624 Reduced 5.35%	11,034 $549,000
Q4 2020 Feb 02, 2021	SELL	$48.52 - $58.02 $14,992 - $17,928	-309 Reduced 2.58%	11,658 $583,000
Q3 2020 Oct 27, 2020	BUY	$53.07 - $61.1 $9,871 - $11,364	186 Added 1.58%	11,967 $656,000
Q2 2020 Jul 16, 2020	SELL	$43.1 - $55.31 $10,904 - $13,993	-253 Reduced 2.1%	11,781 $623,000
Q1 2020 Apr 27, 2020	BUY	$37.79 - $51.33 $32,083 - $43,579	849 Added 7.59%	12,034 $537,000
Q4 2019 Jan 30, 2020	SELL	$42.46 - $50.46 $19,149 - $22,757	-451 Reduced 3.88%	11,185 $558,000
Q3 2019 Nov 01, 2019	BUY	$40.12 - $45.47 $45,135 - $51,153	1,125 Added 10.7%	11,636 $519,000
Q2 2019 Aug 05, 2019	SELL	$37.28 - $41.68 $40,262 - $45,014	-1,080 Reduced 9.32%	10,511 $434,000
Q1 2019 May 01, 2019	BUY	$35.49 - $43.02 $17,709 - $21,466	499 Added 4.5%	11,591 $469,000
Q4 2018 Feb 05, 2019	BUY	$36.86 - $41.49 $32,289 - $36,345	876 Added 8.57%	11,092 $421,000
Q3 2018 Nov 01, 2018	SELL	$34.76 - $39.72 $1,738 - $1,986	-50 Reduced 0.49%	10,216 $404,000
Q2 2018 Jul 30, 2018	BUY	$34.55 - $37.05 $1,243 - $1,333	36 Added 0.35%	10,266 $360,000
Q1 2018 May 08, 2018	BUY	$32.97 - $36.63 $31,849 - $35,384	966 Added 10.43%	10,230 $358,000
Q4 2017 Feb 13, 2018	SELL	$32.09 - $34.78 $8,279 - $8,973	-258 Reduced 2.71%	9,264 $321,000
Q3 2017 Nov 15, 2017	BUY	$28.96 - $34.0 $275,757 - $323,748	9,522 New	9,522 $313,000
Q3 2017 Nov 14, 2017	SELL	$28.96 - $34.0 $202,285 - $237,490	-6,985 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	6,985	6,985 $211,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Astrazeneca PLC Transaction History